- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
| 18.07. | Inspira Technologies: Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement | 185 | GlobeNewswire (Europe) | RA'ANANA, Israel, July 18, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| 17.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
| 10.07. | Inspira Technologies: Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100 | 5 | GlobeNewswire (USA) | ||
| 10.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 07.07. | Inspira Technologies verhandelt mit Regierung über Einsatz von Medizintechnik in der Notfallversorgung | 3 | Investing.com Deutsch | ||
| 07.07. | Inspira Technologies: Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework | 1 | GlobeNewswire (USA) | ||
| 02.07. | Inspira Technologies secures $22.5 million purchase order | 1 | Seeking Alpha | ||
| 01.07. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 23.06. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 11.06. | Inspira Technologies: Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions | 6 | GlobeNewswire (USA) | ||
| 05.06. | Inspira Technologies boosts production of FDA-cleared system | 2 | Investing.com | ||
| 05.06. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 05.06. | Inspira Technologies: Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority | 2 | GlobeNewswire (USA) | ||
| 29.05. | Inspira Technologies ramps up ART100 system commercialization | 4 | Investing.com | ||
| 29.05. | Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System | 330 | GlobeNewswire (Europe) | RA'ANANA, Israel, May 29, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies... ► Artikel lesen | |
| 27.05. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 27.05. | Inspira Technologies strukturiert Führungsteam um | - | Investing.com Deutsch | ||
| 27.05. | Inspira Technologies restructures executive team | 2 | Investing.com | ||
| 27.05. | Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives | 185 | GlobeNewswire (Europe) | RA'ANANA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneering company in advanced respiratory support and diagnostic... ► Artikel lesen | |
| 07.05. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,119 | -4,03 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes | LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,767 | +0,26 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Positive FDA Feedback, Advances Toward IND for (Z)-Endoxifen Clinical Program in ER+/HER2- Metastatic Breast Cancer | SEATTLE, July 29, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines in oncology, today announced... ► Artikel lesen | |
| PING AN HEALTHCARE | 1,388 | +4,91 % | HSI Down 270 pts; HSTI Up 18 pts; MEITUAN Down over 3%; PING AN Down over 3%; MEITU, KINGDEE INT'L, SKB BIO-B, MGM CHINA, PA GOODDOCTOR Hit New Highs | ||
| MOUNTAIN VALLEY MD | 0,011 | -24,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| CO-DIAGNOSTICS | 0,242 | +8,04 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,780 | +2,23 % | Cytosorbents Corp: CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR | PRINCETON, N.J., July 2, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in blood purification therapies for life-threatening conditions... ► Artikel lesen | |
| VERU | 0,448 | +2,94 % | VERU INC. - 8-K, Current Report | ||
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Receives Clearance to Proceed with Pivotal Trial of Amezalpat Combination Therapy for First-Line HCC in China | Builds on clearances already received by FDA and EMAChina has the largest population of patients with hepatocellular carcinoma in the world BRISBANE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Tempest... ► Artikel lesen | |
| VOLITIONRX | 0,700 | 0,00 % | VolitionRx - Nu.Q advances in lung cancer management | Despite rapid advancements in cancer treatments, effective diagnostics for early screening and disease monitoring continue to be an unmet need. This is felt acutely in lung cancer, which is the leading... ► Artikel lesen | |
| EKSO BIONICS | 3,650 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Second Quarter 2025 Financial Results | SAN RAFAEL, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) ("Ekso Bionics" or the "Company"), an industry leader in exoskeleton technology for medical and industrial... ► Artikel lesen | |
| IMUNON | 7,044 | +6,00 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenUS15117N6022 Imunon Inc. 24.07.2025 US15117N7012 Imunon Inc. 25.07.2025 Tausch 15:1US92511W1080 Verrica Pharmaceuticals... ► Artikel lesen | |
| BEYOND AIR | 3,110 | +5,07 % | Beyond Air Awarded Therapeutic Gases Agreement with Premier, Inc. | GARDEN CITY, N.Y., July 22, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air" or the "Company"), a commercial stage medical device and biopharmaceutical company focused on harnessing... ► Artikel lesen | |
| AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| AROVELLA THERAPEUTICS | 0,051 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: Investor Presentation | ||
| NOVACYT | 0,467 | 0,00 % | Novacyt S.A. - Half-year trading update |
INSPIRA TECHNOLOGIES OXY BHN LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,270 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INSPIRA TECHNOLOGIES OXY BHN LTD finden Sie auf Wallstreet Online.